Skip to main navigation Skip to search Skip to main content

Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice

Saikata Sengupta*, Thanh Tu Le, Adam Adam, Vedrana Tadić, Beatrice Stubendorff, Silke Keiner, Linda Kloss, Tino Prell, Otto W. Witte, Julian Grosskreutz

*Corresponding author for this work

Abstract

Motor neurons are markedly vulnerable to excitotoxicity mostly by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptor (AMPAR) stimulation and are principal targets in the neurodegenerative disease Amyotrophic Lateral Sclerosis. Interferon-gamma (IFN-γ), a pro-inflammatory cytokine, can independently cause neuronal dysfunction by triggering calcium influx through a calcium-permeable complex of IFN-γ receptor 1(IFNGR1) subunit and AMPAR subunit GluR1. This receptor complex is formed via a non-canonical neuron-specific IFN-γ pathway that involves Jak1/Stat1 and Protein Kinase A. In this study, we explore the expression of the pathway's participants for the first time in the hSOD1G93A Amyotrophic Lateral Sclerosis mouse model. Elevated IFNGR1 and GluR1 are detected in motor neurons of hSOD1G93A symptomatic mice ex vivo, unlike the downstream targets - Jak1, Stat1, and Protein Kinase A. We, also, determine effects of IFN-γ alone or in the presence of an excitotoxic agent, kainate, on motor neuron survival in vitro. IFN-γ induces neuronal damage, but does not influence kainate-mediated excitotoxicity. Increased IFNGR1 can most likely sensitize motor neurons to excitotoxic insults involving GluR1 and/or pathways mediated by IFN-γ, thus, serving as a potential direct link between neurodegeneration and inflammation in Amyotrophic Lateral Sclerosis.

Original languageEnglish
JournalEuropean Journal of Neuroscience
Volume49
Issue number1
Pages (from-to)62-78
Number of pages17
ISSN0953-816X
DOIs
Publication statusPublished - 01.2019
Externally publishedYes

Funding

This research is supported by BMBF (Bundesministerium für Bildung and Forschung) within the framework of the JPND programme (OnWebDuals) of the European Union and the Deutsche Gesellschaft für Muskelkranke e.V. (DGM) to JG. For the technical assistance, the authors wish to thank Svetlana Tausch and Madlen Günther. This research is supported by BMBF (Bundesministerium f?r Bildung and Forschung) within the framework of the JPND programme (OnWebDuals) of the European Union and the Deutsche Gesellschaft f?r Muskelkranke e.V. (DGM) to JG. For the technical assistance, the authors wish to thank Svetlana Tausch and Madlen G?nther.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Centers: Center for Neuromuscular Diseases

Cite this